SCHEMBL8352200

SCHEMBL8352200

O=C(NCC1CCCCC1)c1cccc(-c2ccnc(Nc3ccccc3)c2)c1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ PIP5K1C O60331 4/20 0.53
▸ PIK3CA P42336 4/20 0.53
▸ MAPK10 P53779 7/20 0.50
▸ MAPK8 P45983 6/20 0.50
▸ MAPK14 Q16539 3/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ POLB P06746 1/20 0.49
▸ ACACB O00763 1/20 0.48
▸ ACACA Q13085 1/20 0.48
▸ ROCK2 O75116 1/20 0.48
▸ ROCK1 Q13464 1/20 0.48
▸ PIP5K1B O14986 1/20 0.48
▸ PIP5K1A Q99755 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8349003 0.84 ATM (0.63) MEN1KMT2APIP5K1CPIK3CAMAPK10
SCHEMBL8354483 0.84 CAMKK2 (0.56) MEN1KMT2AMAPK10MAPK8HDAC6
SCHEMBL1927570 0.83 MEN1 (0.83) MEN1KMT2AHDAC6POLBROCK2
SCHEMBL8352104 0.81 CFD (0.59) MAPK10MAPK8HDAC6ROCK2ROCK1
SCHEMBL29836789 0.79 MEN1 (0.53) MEN1KMT2AHDAC6POLBACACB
SCHEMBL29818223 0.78 MEN1 (0.52) MEN1KMT2AHDAC6POLBACACB
SCHEMBL31331640 0.77 MEN1 (0.71) MEN1KMT2AMAPK14HDAC6POLB
SCHEMBL8351088 0.76 ALDH1A1 (0.62) MEN1KMT2AMAPK10MAPK8POLB
SCHEMBL10722330 0.76 MEN1 (0.81) MEN1KMT2AHDAC6POLB
SCHEMBL29818071 0.76 DGAT1 (0.51) MEN1KMT2AMAPK14HDAC6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
WO-2004041789-A1 COMPOSITIONS USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 — — WO disclosed
Send feedback